- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Debra Patt on What In-person Attendees Can Expect at the Community Oncology Conference
Debra Patt, MD, PhD, MBA, executive vice president of Texas Oncology, speaks on the key discussions to be held at the 2022 Community Oncology Conference for in-person attendees.
By bringing together administrators, clinicians, and policy makers within community oncology, in-person attendees at the 2022 Community Oncology Conference can discuss issues facing their respective practices and formulate collaborative solutions, said Debra Patt, MD, PhD, MBA, executive vice president of Texas Oncology.
Transcript
What can providers and those involved in community oncology gain by being an in-person attendee at the 2022 Community Oncology Conference?
I think that we've all missed seeing each other for the last 2 years, but we've encountered a whole new slew of challenges. The benefit of going to the Community Oncology Alliance meeting is like no other meeting.
It allows you to meet with like-minded individuals that are in community oncology practice—administrators, clinicians, policy makers—and discuss the problems that you've had and formulate collaborative solutions so you can learn from what everyone else is doing. It's a great forum for that and to discuss with people what resources you've developed and share them.
Using AI for the Medical Note: Game Changer or a Bridge Too Far?
July 9th 2025During the “Tech Innovations in Community Oncology” meeting from Tennessee Oncology, oncologists explore artificial intelligence (AI) tools like DeepScribe to enhance documentation efficiency, reduce burnout, and improve patient engagement in clinical settings.
Read More
Managed Care Reflections: A Q&A With David J. Shulkin, MD
July 7th 2025To mark the 30th anniversary of The American Journal of Managed Care (AJMC), each issue in 2025 includes a special feature: reflections from a thought leader on what has changed—and what has not—over the past 3 decades and what’s next for managed care. The July issue features a conversation with David J. Shulkin, MD, a physician and former secretary of the US Department of Veterans Affairs.
Read More
How AI Can Address the Troubled Business Model in Oncology
July 7th 2025Artificial intelligence (AI) will transform community oncology, addressing workforce shortages and reimbursement challenges while enhancing patient care and operational efficiency, discussed speakers at Tennessee Oncology's “Tech Innovations in Community Oncology."
Read More
Alexander I. Spira, MD, PhD, of The US Oncology Network, discusses findings from the COCOON trial that show prophylactic treatment reduces dermatological adverse events in patients with non–small cell lung cancer (NSCLC), enhancing their quality of life during amivantamab therapy.
Read More
